🇺🇸 FDA
Pipeline program

YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.

IFCT-1701

Phase 3 small_molecule active

Quick answer

YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion. for Non small cell lung cancer is a Phase 3 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
CERO THERAPEUTICS HOLDINGS, INC.
Indication
Non small cell lung cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials